Broadwood Partners, Director Bradsher Confirm $12.2M Stake Increase; LeBuhn Exits Reporting Group

summarizeSummary

Activist investor Broadwood Partners and director Neal C. Bradsher confirmed over $12.2 million in recent share purchases, increasing their stake to 32.6%, while Richard T. LeBuhn ceased to be a reporting person.

check_boxKey Events

• Confirmation of Significant Purchases

  Broadwood Partners and director Neal C. Bradsher confirmed recent open market purchases of 670,213 shares for over $12.2 million between March 11-13, 2026.

• Increased Activist Stake

  The reporting group's beneficial ownership now stands at 16,149,742 shares, representing 32.6% of STAAR Surgical's common stock.

• Change in Reporting Group Structure

  Richard T. LeBuhn has ceased to be a reporting person due to the termination of the joint filing and solicitation agreement, altering the formal composition of the activist investor group.

• Continued Shareholder Engagement

  Broadwood Partners maintains its intention to review its investment and engage with the Issuer's management and Board on strategies to enhance shareholder value.

auto_awesomeAnalysis

This Schedule 13D/A provides an updated view of activist investor Broadwood Partners' position in STAAR Surgical. It formally confirms the substantial open market purchases totaling over $12.2 million by Broadwood Partners and director Neal C. Bradsher, which were previously disclosed in a Form 4. These purchases, representing approximately 1.3% of the company's market capitalization, demonstrate strong conviction from a major shareholder and board member, particularly in the wake of the recent negative 10-K report detailing a 23.7% drop in sales and a widened net loss. A key new detail is the termination of the joint filing agreement, resulting in Richard T. LeBuhn ceasing to be a reporting person, which signifies a change in the formal structure of the activist group. Broadwood Partners reiterates its intent to engage with management and the Board to explore avenues for creating additional shareholder value.